NAFDAC, in a statement on its X handle on Monday, said the products were manufactured by Aspen Pharmacare Asia Limited.

It said the recall followed safety concerns approved by the Hong Kong Department of Health.

According to the agency, one batch of Mivacron Injection 0.2 per cent and five batches of Nimbex Injection 2mg/mL were affected.

“The recall was made as a precautionary measure due to potential quality issues identified by the manufacturer,” NAFDAC said.

It said investigations revealed deficiencies in the manufacturer’s manual visual inspection process.

NAFDAC added that “not all glass particles in the ampoules were likely detected,” prompting a voluntary market recall.

The injections, containing mivacurium and cisatracurium, are prescription medicines used as adjuncts to general anaesthesia.

NAFDAC advised healthcare professionals and consumers to report suspected substandard medicines to its nearest office or via its e-reporting platforms  – www.nafdac.gov.ng.

Source: NAN

READ ALSO: 

Calabar: Army rescues 18 abducted Cameroon-bound passengers

Watch! Your corporate culture may have decayed! (I)

Court remands 52 over Ekpoma protest

Police repel bandits’ attack, neutralise two in Kaduna

APC chair to state coordinators: Register every member or be removed

Oba Akran of Badagry joins ancestors, Sanwo-Olu mourns

Three suspects arrested over murder of Abuja-based lawyer, Princess Chigbo

Groups begin activities in honour of late Princess Nwamaka Chigbo

12 die in Yangoji–Abaji multiple-vehicle crash

The post NAFDAC alerts public to recall of Mivacron, Nimbex injections appeared first on Frontpageng.